A Weight Loss Study Evaluating Subcutaneous Treatment With AZD9550 and AZD6234 in Combination Against Placebo or Each of the Drugs Alone

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

374

Participants

Timeline

Start Date

February 18, 2025

Primary Completion Date

June 18, 2026

Study Completion Date

June 18, 2026

Conditions
Obesity or Overweight
Interventions
DRUG

AZD9550

IMP injected subcutaneous, once weekly. Unit dose strength as per CSP

DRUG

AZD6234

IMP injected subcutaneous, once weekly. Unit dose strength as per CSP.

DRUG

Placebo comparator

Placebo matching IMP dose injected subcutaneously, once weekly.

Trial Locations (53)

2035

Research Site, Maroubra

2065

Research Site, St Leonards

3021

Research Site, St Albans

4556

Research Site, Maroochydore

5067

Research Site, Norwood

10787

Research Site, Berlin

14612

Research Site, Falkensee

22206

Research Site, Arlington

22607

Research Site, Hamburg

23758

Research Site, Oldenburg

30030

Research Site, Decatur

30281

Research Site, Stockbridge

34684

Research Site, Palm Harbor

35216

Research Site, Vestavia Hills

36305

Research Site, Dothan

37660

Research Site, Kingsport

43213

Research Site, Columbus

45136

Research Site, Essen

45219

Research Site, Cincinnati

46383

Research Site, Valparaiso

46617

Research Site, South Bend

48034

Research Site, Southfield

48145

Research Site, Münster

51106

Research Site, Sioux City

58104

Research Site, Fargo

59804

Research Site, Missoula

61822

Research Site, Champaign

68114

Research Site, Omaha

74133

Research Site, Tulsa

77043

Research Site, Houston

78526

Research Site, Brownsville

87107

Research Site, Albuquerque

90255

Research Site, Huntington Park

90703

Research Site, Cerritos

92025

Research Site, Escondido

95648

Research Site, Lincoln

95864

Research Site, Sacramento

97504

Research Site, Medford

98057

Research Site, Renton

06708

Research Site, Waterbury

T2V 4J2

Research Site, Calgary

V3T 2V6

Research Site, Surrey

N1G 0B4

Research Site, Guelph

L8J 0B6

Research Site, Hamilton

L8L 5G8

Research Site, Hamilton

N7T 4X3

Research Site, Sarnia

L4A1H2

Research Site, Stouffville

H4N 2W2

Research Site, Montreal

103-0027

Research Site, Chūōku

104-0031

Research Site, Chūōku

812-0025

Research Site, Fukuoka

160-0008

Research Site, Shinjuku-ku

565-0853

Research Site, Suita-shi

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY